Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression
about
Current status and future prospects for epigenetic psychopharmacologyAntidepressants inhibit DNA methyltransferase 1 through reducing G9a levelsEffects of negative stressors on DNA methylation in the brain: implications for mood and anxiety disordersTransient postnatal fluoxetine leads to decreased brain arachidonic acid metabolism and cytochrome P450 4A in adult miceMonitoring candidate gene expression variations before, during and after a first major depressive episode in a 51-year-old man.Potential molecular and cellular mechanism of psychotropic drugsEpigenetic signaling in psychiatric disorders.Epigenetic mechanisms of depression and antidepressant actionAge-associated decrease in global DNA methylation in patients with major depression.Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology.Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene.MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)Telomerase dysregulation in the hippocampus of a rat model of depression: normalization by lithium.Transient postnatal fluoxetine decreases brain concentrations of 20-HETE and 15-epi-LXA4, arachidonic acid metabolites in adult mice.A Longitudinal Study of BDNF Promoter Methylation and Depression in Breast CancerPrenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates.Blood diagnostic biomarkers for major depressive disorder using multiplex DNA methylation profiles: discovery and validationPathogenesis of depression: Insights from human and rodent studies.Probable involvement of p11 with interferon alpha induced depressionCandidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.Brain-derived neurotrophic factor promoter methylation and cortical thickness in recurrent major depressive disorder.Chronic P-glycoprotein inhibition increases the brain concentration of escitalopram: potential implications for treating depressionEpigenetic Modulation of Mood Disorders.Looking beyond the DNA sequence: the relevance of DNA methylation processes for the stress-diathesis model of depressionMAOA gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapy.Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.Elevation of Il6 is associated with disturbed let-7 biogenesis in a genetic model of depression.Serum S100B represents a new biomarker for mood disorders.MicroRNA 101b Is Downregulated in the Prefrontal Cortex of a Genetic Model of Depression and Targets the Glutamate Transporter SLC1A1 (EAAT3) in Vitro.The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis.Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs.Pivotal role of tissue plasminogen activator in the mechanism of action of electroconvulsive therapy.Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment.Epigenetics and depressive disorders: a review of current progress and future directions.Targeting astrocytes in major depression.DNA Methyltransferase Inhibitors: Development and Applications.Gene expression related to serotonergic and glutamatergic neurotransmission is altered in the flinders sensitive line rat model of depression: Effect of ketamine.Glucocorticoid receptor DNA methylation, childhood maltreatment and major depression.Differential effects of early environmental enrichment on emotionality related behaviours in Huntington's disease transgenic mice.An epigenome-wide methylation study of healthy individuals with or without depressive symptoms.
P2860
Q26825464-C4B03BB6-3520-443C-B420-2D4DE434F3C5Q28564940-1381367E-83AB-41E5-82EA-BAE35864DA39Q28822036-691945D6-685B-4559-A7B5-2EF9AA6475ABQ30575789-8924AB7B-BFAA-4E48-A07E-28A95CB8635CQ31153904-31045A1E-0A40-4763-9757-1AAC94D4A15CQ34129880-3409B29C-9CF0-42C9-A2AF-E49EB1FCB85CQ34254501-1BCCA3A4-C0F6-439E-B9AF-D25118871BFFQ34302493-C2902077-6DBE-4D96-B0BE-82E531C50B61Q34530455-16C7282B-48B1-4353-A9B0-EB08E36121A8Q34765123-3F31FCA8-4A92-42CA-B8B5-776D73D90410Q35203658-1142A2D2-12AB-462D-BBA5-AAB65C5974C6Q35954084-4F00FDAA-2F15-42BE-A8C7-18A44D682F9AQ35965875-91BC8B60-F58B-46F5-843C-53B1908B4B43Q36090348-1080E8F2-3C7C-4A5B-8C14-2CC62BADC1CDQ36205428-7F46DD01-770F-4E3C-9062-901C89EE3794Q36213523-714EFD49-F97A-43DA-AB1A-F34B8E72D3A7Q36214173-842BEB97-142B-410F-9608-D1DAB29C1E72Q36332597-A7CD48FB-B843-40B4-A73A-3E6E78E11EA4Q36517077-E120277F-0FB1-41E1-B788-05D19E194BB3Q36539999-1184E669-2053-44E8-839C-EE26F351ABF4Q36579407-49D95906-7189-4974-800C-DF1269B18C09Q36648861-7DF7C76D-B00E-4B0D-BCA3-2F67D09CD039Q36737217-C2B8B5DA-6A70-4FC0-9A1A-63D2A334AC00Q36801188-979CA530-1F18-4B8E-98E3-4FF0FC2F1BA6Q36915362-77760C27-4E60-439A-B394-712735C63B9BQ37058701-072A3B82-66A4-4766-9E4F-D26356D5EF4FQ37254527-0223B040-49D9-42D7-85E2-E5C6D2A49C5EQ37290664-FB86C472-9325-4063-842E-C02C768F9D15Q37547270-3040EFCE-E000-4201-88D7-E0600B004E25Q38057218-68616E82-0380-464C-A4F0-137272B163B3Q38068561-193D19D5-3A71-433B-8647-E46449DB8EC3Q38151373-CD0596D6-2ED9-4D62-A0A7-BD1ECA37BD10Q38154916-D55DFE3F-ED87-43B8-9D27-81C512C32874Q38365358-77171FE8-0CB1-4CA3-80AC-4EF66C472081Q38608401-21F5F413-DB90-4C2D-8386-27F928413BA6Q39003558-2573660F-13F5-477F-9518-90FAB17F3374Q39427905-ED65DDBD-5829-46D2-AF3A-98731FAF3AA6Q40523501-B24B7CC2-E85A-4EFD-995A-15A0B9C3AB38Q42671677-66BA6DB3-66E4-4FD2-8A47-49ACD43EDB08Q47203439-152CDFDD-275D-4235-A8C0-6AF688BD9EE6
P2860
Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression
description
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2012
@ast
scientific journal article
@en
vedecký článok (publikovaný 2012/06/01)
@sk
vědecký článek publikovaný v roce 2012
@cs
wetenschappelijk artikel (gepubliceerd op 2012/06/01)
@nl
наукова стаття, опублікована в червні 2012
@uk
مقالة علمية (نشرت في يونيو 2012)
@ar
name
Antidepressant treatment is as ...... a genetic model of depression
@ast
Antidepressant treatment is as ...... a genetic model of depression
@en
Antidepressant treatment is as ...... a genetic model of depression
@nl
type
label
Antidepressant treatment is as ...... a genetic model of depression
@ast
Antidepressant treatment is as ...... a genetic model of depression
@en
Antidepressant treatment is as ...... a genetic model of depression
@nl
prefLabel
Antidepressant treatment is as ...... a genetic model of depression
@ast
Antidepressant treatment is as ...... a genetic model of depression
@en
Antidepressant treatment is as ...... a genetic model of depression
@nl
P2093
P50
P3181
P1476
Antidepressant treatment is as ...... a genetic model of depression
@en
P2093
Aleksander A Mathé
Anna Witasp
Hongshi Qi
Karl Björk
Maria Rogdaki
Martin Werme
Per Svenningsson
Philippe A Melas
P304
P3181
P356
10.1017/S1461145711000940
P577
2011-06-20T00:00:00Z